Physician profile
John M Allen
NPI 1568505543
$1,065.80
in general payments reported to CMS, 2019-2025
22 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $26.45 · 2021: $78.28 · 2022: $137 · 2023: $121 · 2024: $221 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.23 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $132.39 | 2023-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $103.73 | 2024-2025 | Prolaris |
| Coloplast Corp | $92.16 | 2020-2024 | Speedicath |
| Janssen Biotech, INC. | $82.64 | 2019-2024 | Akeega, Erleada |
| Boston Scientific Corporation | $58.15 | 2025 | Cds - Mct/Cem Monitoring |
| Endo Pharmaceuticals INC. | $47.89 | 2019-2023 | Xiaflex |
| Convatec INC. | $47.86 | 2022-2023 | |
| Urogen Pharma, INC. | $39.51 | 2022 | |
| Allergan, INC. | $38.00 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $33.30 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.74 | 2022-2024 | |
| Verity Pharmaceuticals INC. | $29.72 | 2025 | Trelstar |
| 180 Medical, INC. | $24.66 | 2023 | Gentlecath Glide |
| Olympus America INC. | $20.07 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $20.02 | 2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $18.53 | 2025 | Provenge |
| Lilly USA, LLC | $17.44 | 2025 | Jaypirca, Verzenio |
| Laborie Medical Technologies Corp. | $16.46 | 2022 | |
| Amgen INC. | $15.86 | 2019 | |
| Travere Therapeutics, INC. | $14.49 | 2021 | |
| Abbvie INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.